Osteofibrous Dysplasia

Demographics

Pathogenesis

Symptoms & Signs

Clinical Course

Key Differentials

(For the full behaviour and molecular basis of the two closest mimics, see the dedicated Fibrous Dysplasia, Adamantinoma and Non-Ossifying Fibroma topics; only their OFD-discriminating features are summarised here.)

The histopathology section names the "zoning phenomenon" as the defining microscopic feature, but the term is left undefined - and it is exactly what an examiner means when they slide a low-power photomicrograph across the desk and ask "what is the architectural clue that this is osteofibrous dysplasia and not fibrous dysplasia or adamantinoma?"

What "zoning" (Maturation Gradient) means. In osteofibrous dysplasia the lesion is organised as a centre-to-periphery maturation gradient rather than the haphazard pattern of fibrous dysplasia:

• Centre of the lesion: the most immature and cellular zone - a loose, mildly myxoid fibrous stroma containing irregular woven-bone trabeculae.
• Periphery of the lesion: the bone becomes progressively more mature and lamellar, with the outer trabeculae remodelling and blending into the surrounding host cortex.
• The unifying feature at every level: the woven-bone trabeculae are rimmed by a prominent layer of plump, active osteoblasts (osteoblastic rimming). This osteoblastic rimming is the single most useful discriminator.

Conservative Treatment

Surgical Management

Treatment Algorithm

Decision-Making Framework:

1. Initial Diagnosis (Age less than 10, typical radiographs):

   • Observation with serial imaging
   • No biopsy if classic presentation

2. Atypical Features (Age greater than 10, soft tissue mass, aggressive appearance):

   • MRI to assess soft tissue component
   • Biopsy mandatory (exclude adamantinoma)
   • Consider en bloc resection if adamantinoma-like features

3. Pathological Fracture:

   • Conservative fracture management first
   • Consider curettage if non-union after 6 months
   • Bone grafting to augment healing

4. Progressive Deformity:

   • Observation until skeletal maturity if mild (less than 15 degrees)
   • Corrective osteotomy after maturity if significant (greater than 20 degrees)
   • Address lesion separately if still active

Protective Bracing & Fracture Prophylaxis in the Non-Operative Pathway

The MCQ points and natural-history discussion repeatedly invoke "observation, bracing if needed," but the role of orthotic protection is easily left undefined - a genuine gap for the candidate asked "the family accepts observation; is there anything else you offer?"

Rationale. The lesion weakens the anterior tibial cortex, so the two things that make a purely observed lesion "misbehave" are a pathological fracture (10-15%) and progressive apex-anterior bowing. An external orthosis cannot heal or shrink the lesion, but it can share load across the diaphysis, limit the bending moment on the weakened cortex, and buy time until the lesion becomes quiescent at skeletal maturity.

• When to consider it: a symptomatic or radiographically extensive lesion with significant cortical thinning, activity-related pain, or a healing/healed pathological fracture where the child is remobilising. It is an adjunct to observation, not a substitute for surveillance.
• What is used: a well-moulded clamshell (thermoplastic) tibial orthosis or a patellar-tendon-bearing (PTB)-style ankle-foot orthosis to offload the diaphysis; a simple below-knee brace during high-risk activity is a lower-burden option. Choice is pragmatic - there is no lesion-specific device and no high-level evidence favouring one design.
• What it does NOT do: bracing does not prevent the underlying deformity from progressing if the lesion is biologically active, and it does not replace the definitive answer to established bowing, which is corrective osteotomy near maturity (see Management). Prolonged rigid immobilisation risks stiffness and disuse osteopenia, so protection is graded to activity rather than continuous.
• Fracture that occurs anyway: the great majority (~90%) unite with a standard cast; bracing is the step-down as the child returns to weight-bearing, and non-union (rare) - not the brace - is what triggers surgery.

Complications

Prognosis

Global Epidemiology

• OFD is rare worldwide - well under 0.2% of primary bone tumours - with consistent demographics across published series from Europe, North America and Asia: tibial predominance, anterior cortex of the middle third, and presentation in childhood/adolescence (mean age 7-13 years depending on series).
• No geographic or ethnic predilection and no sex predilection are reported. The largest single dataset is the 101-lesion international series pooling UK and Australian tertiary centres (Dala-Ali, 2022).

Side-by-Side Guidance

There is no single dedicated society guideline for this rare lesion; practice derives from bone-tumour society principles and the major case series. The recommendations below are broadly concordant rather than conflicting.

Registry Notes

• OFD is too rare for dedicated registry survival data. National bone-tumour and sarcoma registries (e.g. the UK NSSG/regional bone-tumour services, European EURACAN reference network, Scandinavian sarcoma group databases) capture it mainly to flag and track the OFD-like adamantinoma it can mimic, where long-term recurrence (beyond 15 years, Houdek 2018) justifies registry surveillance.

High- vs Limited-Resource Practice Variation

• Well-resourced settings: ready access to MRI, immunohistochemistry (cytokeratin/EMA) and specialist sarcoma MDTs allows confident observation of classic lesions and early detection of atypical ones; deformity is managed with planned osteotomy and growth modulation.
• Limited-resource settings: plain radiography remains the mainstay; the key practice point is to AVOID intralesional curettage of a presumed benign lesion that could be an under-sampled adamantinoma, and to refer atypical, painful or progressive cortical tibial lesions to a centre with histopathology and limb-salvage capability rather than treating locally.

Why This Topic Matters in Exams

Globally (FRCS, FRACS, EBOT, ABOS, DNB/MS), examiners test the OFD-adamantinoma-fibrous dysplasia triad: location (cortical vs medullary), cytokeratin nuance, GNAS molecular distinction, the observation-first natural history, and the danger of mislabelling an atypical lesion.

• Is OFD a precursor to adamantinoma? Unresolved. Large paediatric series (Park, Dala-Ali) report NO transformation, arguing OFD is a self-limiting benign lesion. Pathology series (Hazelbag) document OFD-like adamantinomas recurring as classic adamantinoma, supporting a precursor or sampling-bias model. The pragmatic consensus: pure OFD does not need to be treated as pre-malignant, but an atypical or relapsing lesion warrants thorough sampling to exclude OFD-like adamantinoma.
• OFD vs OFD-like adamantinoma on a small biopsy. Scattered keratin-positive cells occur in both; the malignant label requires hyperchromatic epithelial islands. Limited biopsies under-sample, so radiology-pathology correlation and, where feasible, generous sampling are essential.
• Role and timing of biopsy. Classic radiology in a young child can be observed without biopsy. Biopsy is reserved for atypical age (over the second decade), a soft-tissue mass, aggressive radiology, or progression - precisely because needling a benign lesion risks recurrence and offers little when the picture is typical.
• What to operate on. Modern thinking (Dala-Ali) shifts the surgical target from the lesion to the deformity: intralesional curettage has high recurrence and rarely changes natural history, while wide excision carries substantial morbidity. Corrective osteotomy for established angular deformity, ideally near maturity, is increasingly favoured over lesion-directed surgery.
• Surveillance metric. Anterior angular deformity on full-length tibial radiographs (not lesion size alone) is the most useful parameter to follow, with bowing under 10 degrees predicting successful conservative management.

Osteofibrous dysplasia is a rare benign fibro-osseous lesion affecting the anterior tibial cortex in 85-90% of cases, with peak incidence in the first decade of life (mean age 4-8 years). Radiographs show an intracortical lucent lesion with sclerotic borders causing anterior tibial bowing. The critical differential is adamantinoma - osteofibrous dysplasia is cytokeratin negative while adamantinoma is positive. Most cases are managed conservatively with observation as spontaneous resolution commonly occurs after skeletal maturity. Surgery is reserved for pathological fracture (10-15%) or progressive deformity.